Trident Texofab has informed that the board of directors at its meeting held on today has approved unaudited financial result for the quarter and half year ended on September 30, 2019. The Company enclosed copy of unaudited financial results and limited review report. The meeting was commenced at 02.30 pm and concluded at 04.15 pm.
The above information is a part of company’s filings submitted to BSE.